PortViewPortView
Tango Therapeutics logo

Tango Therapeutics (TNGX) Stock Analysis

NASDAQHealthcareBiotechnology

$22.39+0.18%
1-year price historyRange $6.36 – $32.90
52-week range$22.39
$6.25$34.39

What Tango Therapeutics does

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.

Key metrics

Market cap
$3.65B
P/E (TTM)
-26.98
EPS (TTM)
$-0.83
Beta
1.15
Dividend yield
0.00%
Revenue / share
$0.36
50-day avg
$27.49
200-day avg
$19.38
52-week high
$34.39
52-week low
$6.25
CEO
Malte Peters

ETFs linked to TNGX

Broad-market and Healthcare sector ETFs an investor holding Tango Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TNGX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TNGX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Tango Therapeutics?
Tango Therapeutics trades under the ticker TNGX on NASDAQ.
Which exchange is TNGX listed on?
TNGX is listed on NASDAQ.
What sector does Tango Therapeutics operate in?
Tango Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TNGX in a portfolio?
PortView shows TNGX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.